1. Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study 
Georg Griesinger, Henriette Berndt, Laura Schultz, Askan Schultze-Mosgau, Klaus Diedrich, Sören von Otte 
Reproductive BioMedicine Online 
Volume 22, Issue 2, Pages (February 2011)
DOI: /j.rbmo
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

2. Figure 1
Schematic representation of the study protocol. ET=embryo transfer; GnRH=gonadotrophin-releasing hormone; HCG=human chorionic gonadotrophin; MPA=medroxyprogesterone acetate; OHSS=ovarian hyperstimulation syndrome; 2PN=2 pronuclear.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

3. Figure 2
Regression analysis of the relationship between the number of oocytes retrieved and number of fertilized oocytes available for cryopreservation. Line represents quadratic model of the regression equation.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

4. Figure 3
Box plots of the assessment of physical wellbeing on day 3 or 4 after oocyte retrieval by a visual analogue scale. Assessment based on 26 returned questionnaires.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

5. Figure 4
(A) Cumulative incidence of a positive human chorionic gonadotrophin test resulting in a live-born baby. (B) Cumulative incidence of live birth according to vitrified–warmed embryo transfer cycle rank. Dashed lines=intention-to-treat excluding spontaneous pregnancies (n=30); solid lines=patients undergoing at least one vitrified–warmed embryo transfer cycle (n=26).
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions